TetraLogic is at the forefront of the discovery & development of SMAC Mimetics

SMAC Mimetics are promising new anti-cancer therapeutics that activate cancer cell death

Birinapant is one of the most clinically advanced SMAC Mimetics for cancer

Welcome to TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals is a leader in the discovery and development of small molecules called SMAC Mimetics for the treatment of cancers. SMAC Mimetics are an entirely new class of targeted cancer therapeutics designed to specifically induce cancer cell death and inhibit fundamental mechanisms of cancer cell survival and resistance, enabling tumors to die.